Transmitted through the sharing of needles, syringes and other injecting equipment, hepatitis C is the most common infectious disease among injecting drug users in Europe today.In this analysis, the EMCDDA looks at some of the positive advances in treating the disease, including a new generation of medicines.
Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.
James Malar @MalarJames
Sat, 08/01/2020 - 09:40
RT @TBECoalition: For your attention! An Activist’s Guide to Tuberculosis Diagnostic Tools.
These resources are designed to help activists…
TB Activist @TbHivActivist
Fri, 07/31/2020 - 17:47
RT @TBECoalition: For your attention! An Activist’s Guide to Tuberculosis Diagnostic Tools.
These resources are designed to help activists…
TB REP @TbRep
Fri, 07/31/2020 - 12:27
RT @TBECoalition: For your attention! An Activist’s Guide to Tuberculosis Diagnostic Tools.
These resources are designed to help activists…
TB Europe Coalition @TBECoalition
Fri, 07/31/2020 - 11:16
For your attention! An Activist’s Guide to Tuberculosis Diagnostic Tools.
These resources are designed to help acti… https://t.co/PEw3DxTNX2
Alexander Pastoors 🇪🇺🇺🇳🏳️🌈 @AlexPastoorsHIV
Mon, 07/27/2020 - 13:49
RT @Pieter_Brokx: Shocking results of the survey by @aidsactioneurop about the impact of COVID-19 measurements on organizations. https://t.…
Pieter Brokx @Pieter_Brokx
Mon, 07/27/2020 - 12:34
Shocking results of the survey by @aidsactioneurop about the impact of COVID-19 measurements on organizations. https://t.co/T27AZEC5wB
